Pieter A. van der Vleuten

Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial

Alexander Hirsch, Robin Nijveldt, Pieter A. van der Vleuten et al. · European Heart Journal · 2010 · 238 citations · Full text

A proinflammatory monocyte response is associated with myocardial injury and impaired functional outcome in patients with ST-segment elevation myocardial infarction

Anja M. van der Laan, Alexander Hirsch, Lourens Robbers et al. · American Heart Journal · 2011 · 123 citations

Early Electrocardiographic Findings and MR Imaging-Verified Microvascular Injury and Myocardial Infarct Size

Robin Nijveldt, Pieter A. van der Vleuten, Alexander Hirsch et al. · JACC. Cardiovascular imaging · 2009 · 57 citations · Full text

Cardiovascular Disease, Early Electrocardiographic Findings, Myocardial Infarction +11

Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous coronary intervention: Rationale and design of the HEBE trial—A prospective, multicenter, randomized trial

Alexander Hirsch, Robin Nijveldt, Pieter A. van der Vleuten et al. · American Heart Journal · 2006 · 51 citations

Percutaneous Coronary Intervention, Cardiovascular Disease, Intracoronary Infusion +8

Bone marrow cell therapy after acute myocardial infarction: the HEBE trial in perspective, first results

Anja M. van der Laan, Alexander Hirsch, Robin Nijveldt et al. · Netherlands Heart Journal · 2008 · 47 citations · Full text

Thrombosis, Cell Therapy, Bone Marrow Failure +11